Amgen | AMGN - Assets

Amgen reported $65.12B in Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Agios Pharmaceuticals AGIO:US USD 1.24B 58.4M
ALKERMES ALKS:US USD 1.96B 22.08M
Amgen AMGN:US USD 65.12B 1.42B
Astrazeneca AZN:US USD 96.48B 2.3B
Biogen BIIB:US USD 24.55B 300.1M
Biomarin Pharmaceutical BMRN:US USD 6.38B 111.03M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Coherus Biosciences CHRS:US USD 480.85M 70.06M
Exelixis EXEL:US USD 3.07B 110.12M
Genmab GEN:DC DKK 30.28B 408M
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Glaxosmithkline GSK:US GBP 60.15B 167M
Intercept Pharmaceuticals ICPT:US USD 553.71M 5.69M
IONIS PHARMACEUT IONS:US USD 2.53B 111.9M
Mirati Therapeutics MRTX:US USD 1.2B 100.44M
Moderna Inc MRNA:US USD 25.86B 198M
Neurocrine Biosciences NBIX:US USD 2.37B 225.3M
Novartis NOVN:VX USD 117.45B 1.01B
Novartis NVS:US USD 117.45B 1.01B
Ptc Therapeutics PTCT:US USD 1.71B 129.22M
Puma Biotechnology PBYI:US USD 222.06M 23.29M
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Roche Holding ROG:VX 88.15B 1.42B
Sarepta Therapeutics SRPT:US USD 3.13B 27.78M
Seattle Genetics SGEN:US USD 3.67B 55.45M
Takeda 4502:JP JPY 13.5T 1.08T
Teva Pharmaceutical TEVA:IT USD 44.01B 246M
Ultragenyx Pharmaceutical RARE:US USD 1.55B 73.03M
Vertex Pharmaceuticals VRTX:US USD 18.15B 1.44B
YTE INCY:US USD 5.84B 330.77M